期刊文献+

CT、DCE-MRI及超声在卵巢癌诊断及临床分期中的对比分析 被引量:17

Comparative analysis of CT,DCE-MRI and ultrasound in the diagnosis and clinical staging of ovarian cancer
下载PDF
导出
摘要 目的:对比分析电子计算机断层扫描(CT)、动态对比增强磁共振成像(DCE-MRI)及超声在卵巢癌诊断及临床分期中的价值。方法:选取在医院诊治的98例卵巢肿瘤患者,均行CT、DCE-MRI及超声检查,以术后病理检查为诊断标准,比较3种检查方法对卵巢癌及其临床分析的诊断价值。结果:CT和DCE-MRI诊断卵巢癌的准确率分别为87.76%和94.90%,明显高于超声诊断(70.41%),其差异有统计学意义(x^2=8.913,x^2=35.335;P<0.05);CT和DCE-MRI诊断卵巢癌的灵敏度分别为90.57%和98.11%,明显高于超声诊断(75.47%),其差异有统计学意义(x^2=4.283,x^2=11.851;P<0.05);CT和DCE-MRI诊断卵巢癌的特异度分别为84.44%和91.11%,明显高于超声诊断(64.44%),其差异有统计学意义(x^2=4.731,x^2=9.257;P<0.05);CT和DCE-MRI诊断卵巢癌的阳性预测值分别为87.27%和92.86%,明显高于超声诊断(71.43%),其差异有统计学意义(x^2=4.240,x^2=8.765;P<0.05);CT和DCE-MRI诊断卵巢癌的阴性预测值分别为88.37%和97.62%,明显高于超声诊断(69.05%),其差异有统计学意义(x^2=4.753,x^2=12.343;P<0.05)。CT、DCE-MRI诊断卵巢癌临床分期与术后病理检查结果比较差异无统计学意义;超声诊断卵巢癌临床分期Ⅱ期、Ⅲ期与术后病理检查结果比较差异有统计学意义(x^2=4.240,x^2=4.330;P<0.05)。结论:CT、DCE-MRI及超声在卵巢癌及其临床分期中均具有诊断价值,其中CT、DCE-MRI对卵巢癌及其临床分期的诊断性更高,两者联合诊断可提高卵巢癌及其临床分期的诊断准确性。 Objective:To compare and analyze the value of computed tomography(CT),dynamic contrast enhancedmagnetic resonance imaging(DCE-MRI)and ultrasound in the diagnosis and clinical staging of ovarian cancer.Methods:98 patients with ovarian tumor who received diagnosis and treatment in hospital were selected,and all of them underwent CT,DCE-MRI and ultrasound examinations.The postoperative pathological examination was used as diagnostic standard,and the diagnostic value of three examination methods and their clinical analysis on ovarian cancer were compared.Results:The accuracy rates of CT and DCE-MRI in diagnosing ovarian cancer were 87.76%and 94.90%,which were significantly higher than that of ultrasound(70.41%)(x^2=8.913,x^2=35.335,P<0.05),respectively.The sensitivities of CT and DCE-MRI in diagnosing ovarian cancer were 90.57%and 98.11%,which were significantly higher than 75.47%of ultrasound(x^2=4.283,x^2=11.851,P<0.05),respectively.The specificities of CT and DCE-MRI in diagnosing ovarian cancer were 84.44%and 91.11%,which were significantly higher than 64.44%of ultrasound(x^2=4.731,x^2=9.257,P<0.05),respectively.The positive predictive values of CT and DCE-MRI in diagnosing ovarian cancer were 87.27%and 92.86%,which were significantly higher than 71.43%of ultrasound(x^2=4.240,x^2=8.765,P<0.05),respectively.The negative predictive values of CT and DCE-MRI in diagnosing ovarian cancer were 88.37%and 97.62%,respectively,and they were significantly higher than 69.05%of ultrasound(x^2=4.753,x^2=12.343,P<0.05),respectively.There were no significant differences in diagnosing the clinical staging of ovarian cancer and the examination results of postoperative pathology between CT and DEC-MRI,respectively.The differences of stageⅡandⅢof clinical staging of diagnosing ovarian cancer between ultrasound and postoperative pathological examination were significant(x^2=4.240,x^2=4.330,P<0.05),respectively.Conclusion:CT,DCE-MRI and ultrasound have diagnostic value in ovarian cancer and its clinical staging.CT and DCE-MRI have more diagnostic value for ovarian cancer and its clinical staging,and the combined diagnosis of the two methods can improve the diagnostic accuracy of ovarian cancer and its clinical staging.
作者 马永华 孙永 张荣坤 岳都金 贾建国 许守利 MA Yong-hua;SUN Yong;ZHANG Rong-kun(Department of Radiology,Sishui Branch of Jining First People's Hospital(Sishui County People's Hospital),Sishui 273200,China)
出处 《中国医学装备》 2020年第10期90-93,共4页 China Medical Equipment
关键词 电子计算机断层扫描(CT) 磁共振动态增强 超声 卵巢癌 鉴别诊断 Computed tomography(CT) Dynamic contrast enhanced-magnetic resonance Ultrasound Ovarian cancer Differential diagnosis
  • 相关文献

参考文献13

二级参考文献124

  • 1张霖,刘汉菊,金银华,宋扬,闫敏,许珊,申国强.复杂性肛瘘患者MRI与超声诊断对比分析[J].中国老年学杂志,2014,34(2):371-373. 被引量:8
  • 2Schieda N, Avruch L, Flood TA. Small (<l cm) incidental echogenic renal cortical nodules: chemical shift MRI out- performs CT for confirmatory diagnosis of angiomyolipoma (AML) [J]. Insights Imaging, 2014,5 ( 3 ) : 295-299.
  • 3Kingswood JC,Jozwiak S,Belousova ED,et al. Time effect of everolimus on renal angiomyolipoma in patients with tuberous sclerosis complex being treated for subependymal giant cell astrocytoma:subgroup results from the random- ized,placebo-controlled,Phase 3 trial EXIST-I[J]. Nephrol Dial Transplant, 2014,29 (6) : 1203-1210.
  • 4Schieda N, Kielar AZ, A1 Dandan O,et al. Ten uncom- mon and unusual variants of renal angiomyolipoma (AML) : Radiologic-pathologic correlation[J]. Clin Radiol,2015, 70(2) :206-220.
  • 5Kang SK, Huang WC, Pandharipande PV, et al. Solid re- nal masses:What the numbers tell us[J]. Am J Roentgenol, 2014,202(6) : 1196-1206.
  • 6Farrell C1,Noyes SL,Tourojman M,et al. Renal An- giomyolipoma:Preoperative identification of atypical fat- poor AML[J]. Curr Urol Rep,2015,16(3):484.
  • 7Mustafa-Guguli A, Bacalja J, Soipi S, et al. Four bilateral synchronous benign and malignant kidney tumours:A case report[J]. Cesk Patol, 2015,51 ( 1 ) : 50-52.
  • 8Dorin R, Jackson M, Cusano A, et al. Active surveillance of renal masses : An analysis of growth kinetics and clini- cal outcomes stratified by radiological characteristics at diagnosis[J]. Int Braz J Urol, 2014,40 (5) : 627-636.
  • 9Yurkovetsky Z, Skates S, Lomakin A, et al. Development of a multi-marker assay for early detection of ovarian cancer [J].J Clin Oncol, 2010, 28(13):2159-2166.
  • 10Chen X, ZhangJ, Cheng W, et al. CA-125 level as a prognostic indicator in type I and type II epithelial ovarian cancer [J]. Int J Gynecol Cancer, 2013, 23(5):815-822.

共引文献240

同被引文献172

引证文献17

二级引证文献46

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部